Testimony Olumade

913 total citations
9 papers, 97 citations indexed

About

Testimony Olumade is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Testimony Olumade has authored 9 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Testimony Olumade's work include SARS-CoV-2 and COVID-19 Research (2 papers), Vibrio bacteria research studies (2 papers) and Viral Infections and Outbreaks Research (2 papers). Testimony Olumade is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Vibrio bacteria research studies (2 papers) and Viral Infections and Outbreaks Research (2 papers). Testimony Olumade collaborates with scholars based in Nigeria, United States and United Kingdom. Testimony Olumade's co-authors include Judith U. Oguzie, Olusola Ogunsanya, Uwem E. George, Christian Happi, Onikepe Folarin, Kazeem Akano, Jonathan L. Heeney, N N Odunukwe, Abimbola Bowale and Anise N. Happi and has published in prestigious journals such as Scientific Reports, Journal of Medical Virology and PeerJ.

In The Last Decade

Testimony Olumade

9 papers receiving 94 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Testimony Olumade Nigeria	5	67	19	19	12	11	9	97
Luchenga Adam Mucheleng’anga Zambia	6	63 0.9×	15 0.8×	6 0.3×	16 1.3×	21 1.9×	15	129
Rana F Kattan Saudi Arabia	7	108 1.6×	37 1.9×	9 0.5×	3 0.3×	23 2.1×	14	183
Susy Rojas United States	5	81 1.2×	25 1.3×	12 0.6×	8 0.7×	6 0.5×	5	124
Valerie Tulier-Laiwa United States	5	81 1.2×	25 1.3×	12 0.6×	8 0.7×	6 0.5×	5	124
Katja Bengs Germany	3	112 1.7×	8 0.4×	13 0.7×	26 2.2×	4 0.4×	7	141
Susana Rojas United States	5	112 1.7×	35 1.8×	13 0.7×	9 0.8×	6 0.5×	9	164
Audrey Giraud‐Gatineau France	9	126 1.9×	26 1.4×	15 0.8×	25 2.1×	6 0.5×	15	205
Elizabeth Traub United States	5	133 2.0×	38 2.0×	26 1.4×	5 0.4×	2 0.2×	7	177
Shahraz Qamar United States	4	49 0.7×	16 0.8×	5 0.3×	7 0.6×	12 1.1×	6	134
Caroline Targino Alves da Silva Brazil	6	116 1.7×	23 1.2×	18 0.9×	17 1.4×	21 1.9×	6	173

Countries citing papers authored by Testimony Olumade

Since Specialization

Citations

This map shows the geographic impact of Testimony Olumade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Testimony Olumade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Testimony Olumade more than expected).

Fields of papers citing papers by Testimony Olumade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Testimony Olumade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Testimony Olumade. The network helps show where Testimony Olumade may publish in the future.

Co-authorship network of co-authors of Testimony Olumade

This figure shows the co-authorship network connecting the top 25 collaborators of Testimony Olumade. A scholar is included among the top collaborators of Testimony Olumade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Testimony Olumade. Testimony Olumade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Happi, Anise N., Testimony Olumade, Olusola Ogunsanya, et al.. (2022). Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria. Microbiology Spectrum. 10(4). e0036622–e0036622. 11 indexed citations

Ayoade, Femi, Judith U. Oguzie, Kazeem Akano, et al.. (2022). Molecular surveillance of non-O157 Shiga toxigenic Escherichia coli in selected chicken abattoirs and retail outlets in Osogbo, Osun State, Nigeria. 1 indexed citations

Olumade, Testimony, et al.. (2021). Clinical characteristics of 4499 COVID‐19 patients in Africa: A meta‐analysis. Journal of Medical Virology. 93(5). 3055–3061. 22 indexed citations

Ayoade, Femi, Judith U. Oguzie, Philomena Eromon, et al.. (2021). Molecular surveillance of shiga toxigenic Escherichia coli in selected beef abattoirs in Osun State Nigeria. Scientific Reports. 11(1). 13966–13966. 8 indexed citations

Oluniyi, Paul E., Fehintola V. Ajogbasile, Judith U. Oguzie, et al.. (2021). VGEA: an RNA viral assembly toolkit. PeerJ. 9. e12129–e12129. 2 indexed citations

Olumade, Testimony, et al.. (2021). Comparative serologic profiles of hepatitis B Virus (HBV) between HIV/HBV co-infected and Hbv mono-infected patients in Ile-Ife, Nigeria. Journal of Immunoassay and Immunochemistry. 42(6). 633–647. 2 indexed citations

Olumade, Testimony, Bamidele Iwalokun, Chika Onwuamah, et al.. (2020). Clinical and Demographic Characteristics of COVID-19 patients in Lagos, Nigeria: A Descriptive Study. Journal of the National Medical Association. 113(3). 301–306. 20 indexed citations

Olumade, Testimony, et al.. (2020). Infectious disease outbreak preparedness and response in Nigeria: history, limitations and recommendations for global health policy and practice. AIMS Public Health. 7(4). 736–757. 30 indexed citations

Abechi, Priscilla, et al.. (2019). Haemoglobin Genotype, ABO/Rhesus Blood Groups and Malaria among Students Presenting to a Private University Health Centre in Nigeria. American Journal of Biomedical Sciences. 200–208. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact